Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

patient experience

Interview: Steve Bates, BIA

The CEO of the BioIndustry Association discusses the state of UK biotech, its shared ecosystem with pharma and the funding challenges biotech faces

- PMLiVE

Sir Tom Blundell to remain as chair of UK’s biotech research council

Reappointed to government role to support research

- PMLiVE

Online tycoons announce first winners of $33m research prize

Billionaire founders of Facebook and Google among those behind Breakthrough Prize in Life Sciences

Universities launch £50m fund for biopharma start-ups in UK

Will be managed by US group Rock Spring Ventures

Ischemix names David DeWahl as CEO

He joins the US biotech from private investment firm Colchester Healthcare Investments

- PMLiVE

Biotech challenging big pharma for M&A deals

Purchasing power growth of 'big biotech' outpaces pharma sector

- PMLiVE

EC appoints group to examine biotech patent laws

Will examine role of patents in genetic engineering

- PMLiVE

Basilea’s Hans Christian Rohde takes up commercial role at uniQure

Will serve as gene therapy specialist's chief commercial officer

Harren Jhoti and Will West join BIA board

UK biotech trade body welcomes CEOs of Astex Pharmaceuticals and CellCentric

- PMLiVE

Gene therapy: the promise comes closer

After decades of development and a trail of failed clinical trials, gene therapy is finally emerging as a worthwhile approach for treating a range of acquired and inherited diseases

- PMLiVE

Driving early clinical and commercial alignment

Real-world studies can provide evidence to ensure that your brand resonates with your customers

- PMLiVE

Interview: Stephan Tanda, EuropaBio

The chairman of EuropaBio explains to Linda Banks how he believes accelerating uptake of biotechnologies can address European and world challenges

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links